WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8401 Infant (under 12 months) mortality rate: 592
GDP / capita (US$): 1'2301 Child (under 5 years) mortality rate: 792

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 718  700  683  666  649  528  413  314 
Births 26  26  25  25  25  21  16  14 
Surviving infants 24  24  24  23  23  19  14  13 
Pop. less than 5 years 115  114  112  110  108  85  69  57 
Pop. less than 15 years 303  296  288  281  273  219  186  141 
Female 15-49 years 170  166  162  159  156  129  92  69 

Number of reported case

(Click for retrospective incidence data for Comoros (the))
Diphtheria
Japanese encephalitis
Measles 2'328  1'801 
Mumps 109 
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Comoros (the))
Vaccine year result method % card seen                                                
BCG 2011  85  DHS/MICS   72.7  79  90  77  80  81  90  99 
DTP1 2011  82  DHS/MICS   72.7  91  92  81  89  85  85 
DTP3 2011  73  DHS/MICS   72.7  86  83  74  83  81  70  94 
HepB_BD         
HepB3 2009  80  EPI   62.8  86  83  81  83  81 
Hib3          86  83  81  38 
JapEnc         
MCV 2011  75  DHS/MICS   72.7  85  87  72  79  76  70  87 
MCV2         
PCV1         
PCV3         
Pol3 2011  71  DHS/MICS   72.7  85  85  82  84  81  70  94 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  41  MICS   71.4  61  65  38  35  37  40  77 
PAB         
VAD1          18  65  16  21  11 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Comoros (the))
BCG 76  76  76  80  81  90  99 
DTP1 91  92  81  89  85  85  97 
DTP3 86  83  74  83  81  70  94 
HepB3 86  83  74  83  81 
Hib3 86  83  74  38 
MCV 85  87  72  79  76  70  87 
PAB 85  85  85  83  83  57  78 
PCV3
Pol3 85  85  82  84  81  70  94 
Rota_last

Number of districts in the country 17  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 47
From 80 to 89% 18
From 50 to 79% 29
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2014  2011-2014  2011-2014  2007-2011  2007-2011  2007-2001  2002-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 17  17  17  17  13 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 17  17  17  17  17  17  17 
Nº districts with DTP3 coverage >=80% number 11  12  11  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 65  71  35  65  65  53  41 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 35  29  12  18     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   2'238 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.